Medical oncologist at @MGHCancerCenter, Asst. Prof. of Medicine @harvardmed, focusing on patient care and trials in multiple myeloma and plasma cell disorders. Boston, MAJoined May 2009
Super useful table by @bdermanmd for benchmarking depth of response with induction therapy, especially as trials in newly diagnosed MM are starting to include anti-BCMA therapies which may take things further.
Super useful table by @bdermanmd for benchmarking depth of response with induction therapy, especially as trials in newly diagnosed MM are starting to include anti-BCMA therapies which may take things further.
Subcutaneous isatuximab is on the horizon! Press release on phase 3 IRAKLIA study shows s.c. similar to i.v. (as would be expected). Hopefully this will enable approval and availability of s.c. isatuximab soon! sanofi.com/en/media-room/…
This was a very practical poster at #ASH24, looking at prolonged dosing intervals of teclistamab, which is very relevant as dosing of tec (and other bispecific antibodies) moves to q4 week (or even longer intervals).
New recommendation: if dosing interval ≤62 days, no need to…
Thanks @RahulBanerjeeMD! We're looking forward to presenting the poster at ASCO. Excellent outcomes when using daratumumab combinations upfront for patients hospitalized with acute kidney injury (including on dialysis) from myeloma. And this is without plasmapheresis.
Thanks @RahulBanerjeeMD! We're looking forward to presenting the poster at ASCO. Excellent outcomes when using daratumumab combinations upfront for patients hospitalized with acute kidney injury (including on dialysis) from myeloma. And this is without plasmapheresis.
The ODAC on 3/15/24 on cilta-cel and ide-cel was like a plenary or late breaking abstracts session at ASH along with elements of America’s Got Talent. Lots of data being presented, discussion and analysis, and voting too!
23K Followers 3K FollowingProfessor of Hematology; past-president of the EBMT; Chairman of the IACH; Editor in Chief: Bone Marrow Transplant; Clin Hematol Int.
4K Followers 378 FollowingAsst Professor at University of Chicago, specializing in (vanquishing) plasma cell disorders. I tweet about: Myeloma & MRD. https://t.co/mPeWg1QRrW
3K Followers 492 FollowingAssociate Professor of Medicine, Hematology, and Medical Oncology Center of Excellence for Multiple Myeloma @TischCancer @IcahnMountSinai @MountSinaiNYC
7K Followers 476 FollowingHematologist, Myeloma Expert, Communication Enthusiast. Professor at TGen/City of Hope and Chief Medical Officer of the International Myeloma Foundation
4K Followers 2K FollowingWorking hard to bring novel therapies, drug combinations and diagnostics to blood cancer patient.Tweets are my own #precisionmedicine #mmsm #leusm #lymsm
13K Followers 458 FollowingCancer doctor with interest in myeloma, supportive care, end of life, cost-effective/evidence-based care and med-ed. Views own.
8K Followers 442 FollowingOncologist @MGHCancerCenter, Professor @harvardmed, Myeloma doc, clinical trialist, researcher, mom and wife who cares about #myeloma and social issues.
7K Followers 486 FollowingMary and Bill Battle Professor of Multiple Myeloma. Immunotherapy , cellular therapy, clinical trials. I unapologetically believe MM can be CURED.
4K Followers 1K FollowingOncologist and researcher on Myeloma service @mskcancercenter Interested in nutrition 🌱 for cancer and immune therapies. Cancer survivor. Views are my own
3K Followers 337 FollowingHusband and father of 4! 🥋
Director Flow Cytometry Core - CIMA LAB Diagnostics
Director Myeloma Laboratory - Clinica & CIMA Universidad de Navarra
2K Followers 231 FollowingProfessor of hematology at Univ of Iceland. Treatment and research on plasmacell diseases. PI for @iStopMM
https://t.co/56qO3WbcTT…
290 Followers 368 FollowingClinical Research Fellow, Myeloma, Lymphoma and Cellular Therapies, PMCC Toronto 🇨🇦@UHN, @UofT ,Hemat-onc, PGIMER Chd Alumnus, made in 🇮🇳, eternal optimist.
831 Followers 1K FollowingPGY-3 Internal Medicine Resident @LoyolaHealth 🇺🇸 | Alum @ Grant Medical College & Sir J.J. Group of Hospitals 🇮🇳 | Aspiring Heme/Onc🩸 | AAMC ID: 15136839
155 Followers 1K FollowingIMG | Hematology and Medical Oncology @GACancerCenter | Fellowship @MethodistHosp 🩸
IM Resident @MyAkronGeneral | Special Interest in #mmsm & cellular therapy
66 Followers 280 FollowingPhysician scientist working on multiple myeloma @SanRaffaeleMI @MyUniSR. Passionate about cancer cell biology and its translational potential.
415 Followers 5K FollowingYour Antidote to the Oncology Information Flood | Bite-Sized Learning, Built for Busy Schedules. 🔥Largest Hem/Onc Qbank in existence!!
#MedTwitter #HemeOnc.
243 Followers 480 FollowingGeri Heme/Onc Fellow @BUMedicine | IM @SouthBKHealth MBBS @fmciofficial 'For what does it profit a man, to gain the whole world and forfeit his life?' Mark 8:36
300 Followers 977 FollowingMedical Oncology Fellow at Dana-Farber Cancer Institute/Mass General Brigham | IM Residency at MGH '25 | MD/PhD '23 at UT Southwestern | he/him
87 Followers 162 FollowingAsst Prof @VCUMassey via @TuftsMedicalCtr & @CookCtyHealth | Hematologist with a focus on plasma cell disorders | Views are my own. 🇵🇰🇺🇸
2K Followers 2K FollowingIndependent Medical Education in the detection of biomarkers & targetable alterations for personalised cancer management. https://t.co/dgc8eqQrcl
114 Followers 322 FollowingRapid Novor Dx's EasyM™ is a non-invasive, blood-based MRD test for MM, tracking unique M-protein peptides via mass spectrometry for precise monitoring.
12K Followers 85 FollowingProfessor of Medicine, Chief of Myeloma Division & Translational Clinical Oncology Program. Sylvester Comprehensive Cancer Center, Univ of Miami. Tweets = mine
23K Followers 3K FollowingProfessor of Hematology; past-president of the EBMT; Chairman of the IACH; Editor in Chief: Bone Marrow Transplant; Clin Hematol Int.
4K Followers 378 FollowingAsst Professor at University of Chicago, specializing in (vanquishing) plasma cell disorders. I tweet about: Myeloma & MRD. https://t.co/mPeWg1QRrW
3K Followers 492 FollowingAssociate Professor of Medicine, Hematology, and Medical Oncology Center of Excellence for Multiple Myeloma @TischCancer @IcahnMountSinai @MountSinaiNYC
7K Followers 476 FollowingHematologist, Myeloma Expert, Communication Enthusiast. Professor at TGen/City of Hope and Chief Medical Officer of the International Myeloma Foundation
4K Followers 2K FollowingWorking hard to bring novel therapies, drug combinations and diagnostics to blood cancer patient.Tweets are my own #precisionmedicine #mmsm #leusm #lymsm
13K Followers 458 FollowingCancer doctor with interest in myeloma, supportive care, end of life, cost-effective/evidence-based care and med-ed. Views own.
8K Followers 442 FollowingOncologist @MGHCancerCenter, Professor @harvardmed, Myeloma doc, clinical trialist, researcher, mom and wife who cares about #myeloma and social issues.
7K Followers 486 FollowingMary and Bill Battle Professor of Multiple Myeloma. Immunotherapy , cellular therapy, clinical trials. I unapologetically believe MM can be CURED.
4K Followers 1K FollowingOncologist and researcher on Myeloma service @mskcancercenter Interested in nutrition 🌱 for cancer and immune therapies. Cancer survivor. Views are my own
3K Followers 337 FollowingHusband and father of 4! 🥋
Director Flow Cytometry Core - CIMA LAB Diagnostics
Director Myeloma Laboratory - Clinica & CIMA Universidad de Navarra
21K Followers 3K FollowingIn their award-winning podcast, Alice and Brett bring their unique perspective to the most famous mysteries. CrimeCon 2023 Creator of the Year Award.
4K Followers 358 FollowingAssociate Professor,Plasma Cell disorder program Director, Division of HMCT/University of Kansas Medical Center, no COI, #USMIRC Founder, #mmsm @KUMedCenter
87 Followers 162 FollowingAsst Prof @VCUMassey via @TuftsMedicalCtr & @CookCtyHealth | Hematologist with a focus on plasma cell disorders | Views are my own. 🇵🇰🇺🇸
307K Followers 1K FollowingNew York Times columnist, visiting professor @lipscomb, Chautauqua Perry Fellow in Democracy, Iraq vet, married to @NancyAFrench.
268 Followers 252 FollowingDedicated to communicating emerging science from AbbVie in Oncology. Please see our community guidelines: https://t.co/QNcTOBdm6Y. Intended for US HCPs only.
1K Followers 573 FollowingHematologist/Oncologist and @nyulisom_hemonc Fellowship Program Director @nyulangoneli #hemeonc #multiplemyeloma #myeloma #mmsm #lymphoma. Tweets are my own.
808 Followers 261 FollowingAssistant Professor, Myeloma Institute @SylvesterCancer. Former @MSKCancerCenter chief fellow. Opinions expressed are my own.
1K Followers 825 FollowingVP of Oncology Global Medical Affairs at Johnson & Johnson, focused on bringing new treatment options for pts with cancer. Tweets/views shared are my own
8K Followers 2K Following@mghsurgery/@osusurgery alum; breast surgeon. Passionate about breast cancer, women in surgery, ergonomics, writing, promoting trainees and art/creativity!